It has been suggested that elevated HbA1c at diagnosis of T1D, beyond an increase in the prevalence of DKA at onset, may be the consequence of a delay in diagnosis and insulin treatment initiation secondary to the pandemic difficulties [136]. This evidence concerns the gene INS and type 1 diabetes mellitus.